Trademark: 87641236
Status Date
Monday, September 20, 2021
Filing Date
Wednesday, October 11, 2017
Abandoned Date
Thursday, September 9, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Sep 20, 2021
Abandonment Notice E-Mailed - Failure To Respond
Sep 20, 2021
Abandonment - Failure To Respond Or Late Response
Mar 8, 2021
Notification Of Non-Final Action E-Mailed
Mar 8, 2021
Non-Final Action E-Mailed
Mar 8, 2021
Non-Final Action Written
Mar 8, 2021
Lie Checked Susp - To Atty For Action
Jul 15, 2020
Report Completed Suspension Check Case Still Suspended
Jan 14, 2020
Report Completed Suspension Check Case Still Suspended
Jul 11, 2019
Report Completed Suspension Check Case Still Suspended
Jan 11, 2019
Report Completed Suspension Check Case Still Suspended
Jan 11, 2019
Assigned To Lie
Jun 7, 2018
Undeliverable Mail - Courtesy Copy Mailed
May 31, 2018
Notification Of Letter Of Suspension E-Mailed
May 31, 2018
Letter Of Suspension E-Mailed
May 31, 2018
Suspension Letter Written
May 30, 2018
Teas/Email Correspondence Entered
May 29, 2018
Correspondence Received In Law Office
May 29, 2018
Teas Response To Office Action Received
Jan 11, 2018
Notification Of Non-Final Action E-Mailed
Jan 11, 2018
Non-Final Action E-Mailed
Jan 11, 2018
Non-Final Action Written
Jan 10, 2018
Assigned To Examiner
Oct 18, 2017
New Application Office Supplied Data Entered In Tram
Oct 14, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
